Delivery Order SPE2DB22D2211-SPE2DB25FSDBB
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $11,258.62 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count packages). The contract is a firm fixed price delivery order with an ultimate completion date of July 31, 2025, and was competitively awarded with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in the same municipality. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $95,172.85 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) on August 26, 2025, with completion targeted for August 27, 2025. This competitive award, issued under firm fixed pricing terms, supports federal medical procurement needs through AmerisourceBergen's established supply chain. The contract specifies performance from the vendor's location in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency awarded a delivery order valued at $6,283.59 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count) on August 6, 2025, with ultimate completion scheduled for August 7, 2025. This non-competitive delivery order utilizes firm fixed price terms and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December...
- The Defense Logistics Agency awarded a delivery order valued at $34,348.79 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) on August 20, 2025, with completion expected by August 21, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The place of...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,789.52 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) on August 27, 2025, with an ultimate completion date of August 28, 2025. This competitively awarded, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December...
- The Defense Logistics Agency awarded a delivery order valued at $83,800.36 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units). This competitive award, issued on July 22, 2025, with an ultimate completion date of July 23, 2025, represents a firm fixed-price delivery order with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, and serves the federal medical supply chain...
- The Defense Logistics Agency awarded a $3,284.65 delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Eliquis 5 mg tablets (60-count). This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of July 15, 2025. The pharmaceutical product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $29,515.37 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count packages). This competitively awarded, firm fixed-price contract was issued on July 29, 2025, with an ultimate completion date of July 30, 2025. The order will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract issued under AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a delivery order valued at $32,737.72 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units) on September 15, 2025, with an ultimate completion date of September 16, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child award under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Eliquis 5 mg tablets (60-count packages) valued at $11,416.41. This firm fixed-price delivery order is non-competitive and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which carries a total value of $999,999,999.00 through December 2026. The work is to be performed at AmerisourceBergen's...
- SPE2DB22D2211Indefinite Delivery Contract
- SPE2DB22D2211-SPE2DB25FSDBBDelivery Order
The Defense Logistics Agency has awarded a delivery order valued at $123,658.99 to AmerisourceBergen Drug Corp for the supply of Eliquis 5 mg tablets (60-count units). This competitively awarded, firm fixed-price delivery order, issued on August 18, 2025, with an ultimate completion date of August 19, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical. The contract contains no set-aside designation, reflecting the company's demonstrated capability to compete successfully in the federal pharmaceutical supply market. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a major pharmaceutical distributor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company holds a comprehensive IDC with DLA Troop Support Medical valued at $999,999,999.00 through December 2026, which serves as the overarching vehicle enabling deliveries of a broad range of pharmaceutical products and medical supplies to support global military healthcare operations. This delivery order for Eliquis, an anticoagulant medication, exemplifies AmerisourceBergen's role as a critical vendor in the federal supply chain, delivering specialty medications across multiple therapeutic domains to the Defense Health Agency and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $123.7k | 8/18/25 |